Related Experiment Video
Updated: Aug 5, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Effects of oral perhexiline on canine myocardial flow distribution
Insights
Perhexiline maleate increases the endocardium to epicardium ratio during reduced coronary flow, suggesting it redistributes blood flow. This drug
Area of Science:
- Cardiovascular pharmacology
- Myocardial blood flow dynamics
Background:
- Perhexiline maleate is used for angina.
- Its effect on regional coronary flow distribution is not fully understood.
Purpose of the Study:
- To investigate the effect of perhexiline maleate on regional transmural coronary resistance.
- To determine if perhexiline maleate alters coronary flow distribution during normal and reduced flow states, and in myocardial infarction.
Main Methods:
- Administration of perhexiline maleate to normal dogs.
- Measurement of relative regional transmural resistance.
- Induction of acute myocardial infarction.
- Correlation analysis between drug plasma concentration and endo:epi ratio.
Main Results:
- Perhexiline maleate increased the endocardium:epicardium (endo:epi) ratio during reduced coronary flow in normal dogs.
- In acute myocardial infarction, heart rate was lower, and the endo:epi ratio of perfused areas increased under normal coronary flow.
- A linear relationship was found between the endo:epi ratio and plasma concentrations of perhexiline and its metabolite.
Conclusions:
- Perhexiline maleate appears to redistribute coronary blood flow, favoring the endocardium.
- This mechanism may contribute to its anti-anginal effects.
- The drug's action is dose-dependent and related to plasma concentrations.
Abstract:
Perhexiline maleate at a dose of 400 mg three times daily for 2 days administered to normal dogs altered the relative regional transmural resistance so that during reduced coronary flow the endocardium:epicardium (endo:epi) ratio is increased. In the presence of acute myocardial infarction heart rate was significantly lower and the endo:epi ratio of perfused areas was increased when coronary flow was normal. A linear relationship was observed between the endo:epi ratio and the concentration of perhexiline in plasma, and its monohydroxyl metabolite in plasma. The results suggest that the mechanism of action of the drug is due to redistribution of a limited coronary flow.

